|
|
||||||||
From the Department of Clinical Neuroscience (Drs. OSullivan, Pereira, and Markus), St. Georges Hospital, and Department of Neuroimaging (Drs. Lythgoe, Summers, Jarosz, and Williams), Kings College Hospital and Institute of Psychiatry, London, UK.
Address correspondence and reprint requests to Dr. Mike OSullivan, Dept. of Clinical Neuroscience, St. Georges Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK; e-mail: m.osullivan{at}sghms.ac.uk
Background: Ischemic leukoaraiosis (ILA) refers to diffuse T2-weighted white matter hyperintensity in the context of a previous clinical lacunar stroke. Reduced cerebral blood flow (CBF) in white matter has been demonstrated, but it is not known whether hypoperfusion is confined to lesions or extends into normal-appearing white matter. Demonstrating changes in normal-appearing white matter would provide clues to the importance of hypoperfusion in pathogenesis and would be an obvious target for therapies aimed at restoring white matter blood flow.
Methods: Twenty-one patients with ILA, and 16 age-matched control subjects, underwent exogenous contrast-based quantitative perfusion MRI. CBF was determined both within and outside areas of T2-weighted hyperintensity in both periventricular white matter and the centrum semiovale.
Results: CBF of normal-appearing white matter was reduced in periventricular regions (for patients with ILA, 17.9 ± 5.6 mL/100 g/min; for controls, 21.6 ± 5.1 mL/100 g/min; p = 0.046). CBF in gray matter and normal-appearing white matter of the centrum semiovale did not differ significantly between groups. In normal-appearing white matter in patients, CBF was higher in the centrum semiovale than periventricular white matter, with a similar trend in control subjects.
Conclusions: Hypoperfusion may be an early feature in the development of periventricular lesions in ILA and may play a direct pathogenic role. Serial studies are now needed to determine whether these changes herald the appearance of new lesions and represent at risk white matter, and to determine whether pharmacological agents can restore perfusion of normal-appearing white matter.
This article has been cited by other articles:
![]() |
H. Ay, E. M. Arsava, J. Rosand, K. L. Furie, A. B. Singhal, P. W. Schaefer, O. Wu, R. G. Gonzalez, W. J. Koroshetz, and A. G. Sorensen Severity of Leukoaraiosis and Susceptibility to Infarct Growth in Acute Stroke Stroke, May 1, 2008; 39(5): 1409 - 1413. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Holland, E. E. Smith, I. Csapo, M. E. Gurol, D. A. Brylka, R. J. Killiany, D. Blacker, M. S. Albert, C. R.G. Guttmann, and S. M. Greenberg Spatial Distribution of White-Matter Hyperintensities in Alzheimer Disease, Cerebral Amyloid Angiopathy, and Healthy Aging Stroke, April 1, 2008; 39(4): 1127 - 1133. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O'Sullivan Leukoaraiosis Practical Neurology, January 1, 2008; 8(1): 26 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Markus Genes, endothelial function and cerebral small vessel disease in man Exp Physiol, January 1, 2008; 93(1): 121 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Khan, L. Porteous, A. Hassan, and H. S Markus Risk factor profile of cerebral small vessel disease and its subtypes J. Neurol. Neurosurg. Psychiatry, July 1, 2007; 78(7): 702 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Palumbo, J. M. Boulanger, M. D. Hill, D. Inzitari, A. M. Buchan, and on behalf of the CASES Investigators Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke Neurology, March 27, 2007; 68(13): 1020 - 1024. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Kuller Green Banana*: Dementia Epidemiology Research: It Is Time to Modify the Focus of Research J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2006; 61(12): 1314 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Birns, H. Markus, and L. Kalra Blood Pressure Reduction for Vascular Risk: Is There a Price To Be Paid? Stroke, June 1, 2005; 36(6): 1308 - 1313. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Enzinger, F. Fazekas, P. M. Matthews, S. Ropele, H. Schmidt, S. Smith, and R. Schmidt Risk factors for progression of brain atrophy in aging: Six-year follow-up of normal subjects Neurology, May 24, 2005; 64(10): 1704 - 1711. [Abstract] [Full Text] [PDF] |
||||
![]() |
J M Wardlaw What causes lacunar stroke? J. Neurol. Neurosurg. Psychiatry, May 1, 2005; 76(5): 617 - 619. [Full Text] [PDF] |
||||
![]() |
D. M. Moody, C. R. Thore, J. A. Anstrom, V. R. Challa, C. D. Langefeld, and W. R. Brown Quantification of Afferent Vessels Shows Reduced Brain Vascular Density in Subjects with Leukoaraiosis Radiology, December 1, 2004; 233(3): 883 - 890. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. van der Grond, A. F. van Raamt, Y. van der Graaf, W. P.T.M. Mali, and R. H.C. Bisschops A fetal circle of Willis is associated with a decreased deep white matter lesion load Neurology, October 26, 2004; 63(8): 1452 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tullberg, E. Fletcher, C. DeCarli, D. Mungas, B. R. Reed, D. J. Harvey, M. W. Weiner, H. C. Chui, and W. J. Jagust White matter lesions impair frontal lobe function regardless of their location Neurology, July 27, 2004; 63(2): 246 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sachdev, W. Wen, R. Shnier, and H. Brodaty Cerebral Blood Volume in T2-Weighted White Matter Hyperintensities Using Exogenous Contrast Based Perfusion MRI J Neuropsychiatry Clin Neurosci, February 1, 2004; 16(1): 83 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Soinne, J. Helenius, E. Saimanen, O. Salonen, P. J. Lindsberg, M. Kaste, and T. Tatlisumak Brain diffusion changes in carotid occlusive disease treated with endarterectomy Neurology, October 28, 2003; 61(8): 1061 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Harbison, G. J. Gibson, D. Birchall, I. Zammit-Maempel, and G. A. Ford White matter disease and sleep-disordered breathing after acute stroke Neurology, October 14, 2003; 61(7): 959 - 963. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Inzitari Leukoaraiosis: An Independent Risk Factor for Stroke? Stroke, August 1, 2003; 34(8): 2067 - 2071. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |